February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias.Â
February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, revealed findings from a company-funded study of real-world data.
February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.
February 1, 2024 — Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life?
February 1, 2024 —  Genomics plc (Genomics), a healthcare company aiming to transform health through the power of genomics, today announced that the results of itsÂ
February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.
If you enjoy this content, please share it with a colleague
January 31, 2024 — Royal Philips, a global leader in health technology, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has re